<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 148 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page147.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=148">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 148 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 148</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=148"><img src="../thumb/148.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Cardio-Vascular Agents - 7.3.9                                                 2020-04 / 117
       Dosage: Recomm.dos: One tab/day. Max.eff. seen within 2-4 wks.   Special precautions: Correct Na & vol.deplet. bef.init.ther.,   (S3) TABS. 29/7.1.3/0268, 36/7.1.3/0490
                                         -
       When clinic.appropr.admin. 160(12,5)mg or 160(25)mg strengths.  concom.K-spar.diuret./-supplem. /-salt substit./meds.that may alt.  818739-002: 50 mg, 30, R128,43
       Contraindications: Prev.ACE inhibit./angiotens. recept. block.  K  lev., monit.ser. K , monit.concom.Li, incr.mortalit.in HF pts.receiv.   710079-001: 100 mg, 30, R128,43
                                             +
                                     +
       angioed.hist., heredit./idiopath. angioed., hypertroph.obstruct.car-  ACE inhibit./beta-block.theref.not recomm., digital. induc. card.ar-  Dosage: May be admin.with other antihypertens./ insulin.& com-
       diomyopathy, anuria, mod.to sev.ren.impairm., bil.ren.artery stenos.,   rhythm.due to.hypokalaem/ hypomagnesaem., concom.insulin &   mon hypoglycaem.agents
                              +
       ren.artery stenos.with sngl.kidn., aort. stenos., concom.K -spar.diuret.,   oral antidiabet. dos.adjustm., hepat.impairm.hist., gluc. tol.poss.alt.,   Hyptertens: Init & maint dos: 50 mg once dly. Max. eff.attain. 3-6
       porphyr., Addison’s dis., Li ther., pregn.& lactat., sev.hepat. impairm.,   triglycer./cholesterol & uric acid lev.rais.  wks.aft.initiat. May be incr.to 100 mg once dly. Intravasc.vol.de-
       bil.cirrhos.& cholestas., refract. hypokalaem., hyponatraem., hyper-  Drug interactions: Other antihypertens.drugs may incr.antihyper-  plet: Init dos: 25 mg once dly.
       calcaem.& symptomat. hyperuricaem., safety & effic.in childr. not   tens.eff., antihypertens.& diuret. eff.weak.by NSAID’s, sympatho-  Ren.protect.in type 2 diab.with hypertens.& proteinur: Usual
       est., concom.renin inhibit.eg aliskrien-contain. prod.  mimet. reduc.antihypertens.eff., rev.incr.in ser.Li conc.& toxic.with   start.dos.50 mg once dly. May be incr. to 100 mg once dly.based
       Side effects: Common: Incr.bld lipids, hypomagnesaem., hyperuri-  concur.ACE inhib.& thiazides, act.of curare derivat.potent., kaliuret.  on BP respons.
       caem., decr.appet., orthostat.hypotens., N&V, urticar., rash. Uncom-  diuret./ corticoster. /ACTH/amphotericin/carbenoxolone / penicill.G   Contraindications: Angio-oed.relat.to ACE-inhibit./ angiotensin
       mon: Dehydrat., paraesthes., blurr.vis., tinnit., hypotens., cough,   & salicylic acid.deriv.may incr. hypokalaem. eff., incr.hypersens.re-  receptor antagon., hypertroph. obstruct. cardiomyopathy, sev.ren.
       myalg., fatig. Rare: Thrombocytopen., purpura, photosens.react.,   acts.to allopurinol, incr.advers.effs.from amantadine, enhanc. hy-  impairm., hepat. impairm., aortic.stenos., L ventric.outflow track
       decr. libido, leucopen., agranulocytos., bone marr. fail., haemolyt.  perglycaem.eff.of diazoxide, reduc. ren. excret.of cytotox.drugs po-  obstruct., bilat.ren.artery stenos., ren.artery stenos. in pts.with sngl.
       anaem., necrotis. vasculit., vasc. disords, hypercalcaem., hypergly-  tent.their myelosuppress. effs., anticholinerg.agents incr. bioavail.,   kidn., concom.K -spar.diuret., pregn., lactat., safety in childr.not est.,
                                                                         +
       caem., glucosur., worsen. of diabet. metabol. state, hypochloraem.   haemolyt.anaem.with methyldopa, cholestryamine decr.absorpt.,   safety in porphyr. not est.
       alkalos., metabol. alkalos., sleep disords., depress., dysrhythm.,   vit.D or Ca salts potent. rise in ser.Ca, cyclospor.may incr.risk of hy-  Side effects: URTI, insomn., headache, dizzin., vertigo, palpitat.,
       pancreatit., cholestas., jaund., tox. epiderm. necrolys., cutan. lupus-  peruricaem. & gout type complicat., alcoh./ barbitur/ narcot.may   tachycard., orthostat.hypotens., cough, pharyngit., nas.congest., si-
       erythematos.-like reacts., reactivat.of cutan. lupus erythematos. Very   potent.orthostat.hypotens.  nus disords., GI disturbs., rash, back pain, musc.cramps, oed., swell.,
       rare: Dizzin., diarrh., arthralg. Unknown: Neutropen., hypokalaem.,   COAPROVEL, Sanofi-Aventis   chest pain, fatig./asthen., hyperkalaem., elev. ALT, anaem., anaphy-
       hyponatraem., syncope, non-cardiogen. pulm.oed., ren.impairm./-  lact.reacts.in some pts. prev.treat.with ACE inhibit./angioten.recept.
       fail./-disord., incr. bld.uric acid/bilirub./creatinine./urea, abdom.   Irbesartan 150(300) mg, hydrochlorothiazide 12,5(12,5) mg  block., migraine, dysgeus., erect.dysfunct., impot., vasculit., cough,
                                     Indications: Essent.hypertens.in pts.stabil.on same dos.of in-
       pain/upper abdom.pain, anx., arthrit., asthen., back pain, bronchit/  hepatit., abnorm.liv.funct., urticar., prurit., erythroderma, photosens.,
       ac.bronchit., chest pain, postur. dizzin., dyspeps., dyspn., dry mouth,   div.compon.  myalg., arthralg., thrombocytopen., malaise.
       epistax., erect.dysfunct., gastroenterit., headache, hyperydros., hy-  (S3) TABS, 33/7.1.3/0324, 0325  Special precautions: Teratogen.in experim. anim., adeq.contracept.
                                     891353-004: 150/12,5 mg, 28, R310,49
                                                                                  +
       poesthes., influenza, insomn., ligam.sprain, musc.spasms/-strain,   for women of childbear. age, monit.ser.K  lev.reg., comprom.ren.funct.,
       nas. congest., nasopharyngit., neck pain, oed., periph. oed., otit. me-  898597-005: 300/12,5 mg, 28, R307,68  correct electrol./fluid imbal.bef.init.treatm., hepat. impairm., imp.ren.
                                     Dosage: 1 tab.dly. If BP not adeq.control.another antihypertens.
       dia, pain in extrem., palpitats, pharyngolaryng. pain, pollakiur., pyrex.,   may be add.  funct., where ren.funct.depends on renin-angiotens.-aldoster.syst.
       rash, sinusit., sinus congest., somnol., tachycard., URTI, UTI, vertigo,   activ., ren.artery stenos., pts.with comprom.ren.funct.recd.NSAIDs
                                                                                            +
       vir.infects., vis.disturb., angioneurot. oed., prurit., hypersens./ allerg.   Contraindications: Hypersens.to sulphonam.-deriv. drugs, anuric,   Drug interactions: Meds.block.angiotens.II or it’s effs./K -spar.
                                     safety in pregn.& lactat.not est., safety & effect.in paed.pts.not est.,
                                                                                     +
                                                                      +
                                                                            +
       reacts., vasculit., myalg., incr.bld.K, aplast. anaem, angle-clos.glauc.,   diuret./ K  supplem./K salt substit. incr. ser. K , Li excret.reduc., effs.
       erythema multiforme, asthen.  sev. ren./ hepat.impairm.    attenuat.by NSAID’s incl.COX 2-inhibit.
       Warnings and special precautions: No rechalleng. aft.angioed.   Side effects: Headache, dizzin., fatig., GI disturbs., oed., chest pain,   (S3) COZAAR COMP, [N/P/S]
                                     cough, sex.dysfunct., tachycard., orthostat.dizzin., pancreatit., sialad-
       react., treatm.to be stop. & chang.if pregn.occurs/plan., dual block.  Losartan potassium 50(100)mg, hydrochlorothiazide 12,5(12,5)mg.
       of RAAS with ARB’s/ACE inhibit./aliskiren assoc. with high. freq.hy-  enit., vertigo, paraesthes., xanthops., bld. dyscras., photosens.reacts.,   Indications: Hypertens.in pts.est.on identic.dos.of the indiv.ingred.
                                     fev., urticar., necrotis. angit., resp.distress, anaphylact.reacts., tox.
       potens./hyperkalaem.& decr. ren. funct., correct Na & vol.deplet.bef.  epiderm. necrolys., hyperglycaem., glycosur., hyperuricaem., electrol.  TABS. 30/7.1.3/0284, 46/7.1.3/0865
       init.ther., concom. K-spar. diuret./-supplem./-salt substit., meds. that   828181-004: 50/12,5 mg, 30, R145,41
               -
                  +
           +
       may alt.K  lev., monit.ser.K , mild-mod. hepat. impairm., SLE poss.ac-  imbal., ren.dysfunct., interstit. nephrit., musc.sp., weakn., restlessn.,   723331-001: 100/12,5 mg, 30, R145,41
                                     trans. blurr.vis., ac.gout attack in suscept.indiv., activat./exacerbat.of
       tiv./exacerbat., gluc. tol. poss. alt., triglycer./cholesterol & uric acid   Dosage: 1 tab. (50/12,5 mg) once dly. May be incr. to max.dos. of 2 x
       ser. lev. poss.rais., ren.funct.assessm in post MI & HF pts., concurr.  SLE, incr.serum Ca lev., jaund.  50/12,5 mg tabs.once dly in pts. not respond.adeq. Max.therap.eff.
                                     Special precautions: Correct Na & vol.deplet. bef.init.ther., bi-/
       hypovolaem. poss.induc. ac. ren. fail., digital. induc.card. arrhythm.  unilat.ren.art.stenos., sev.CHF, post sympathectomy pt., progress.liv.  attain.with. 3 wks. aft.ther.init.100/12,5 mg tabs avail.for pts. titrat.
                                                                  to Cozaar 100 mg where addit.contr.requir. May be admin.with other
       due to hypokalaem/ hypomagnesaem., concom.insulin & oral antidia-
       bet. agents dos.adjustm. discont. immed.if angioed. report.& do not   dis., poss. incr.insul.requirem.in diabet., latent diabet.mellit. evid.,   antihypertens.agents esp. Ca chann.blocks./beta blocks.
                                     monit.pts.at risk of electrol.& metabol. disturbs., monit.serum Ca
       re-chall., urin. Ca excret. decr.lead.to poss.elev.ser. Ca in absence of   with concom.Ca  Contraindications: Angioed.hist.relat.to prev. ACE inhib./angiotens.
                                                                  recept.blocks., heredit./ idiopath. angioed., hypertroph.obstruct. car-
       known Ca metabol.disords., concom. ser.Li monit., discont.hydrochlo-  Drug interactions: Other antihypertens.drugs may incr.antihyper-
       rothiaz.if ac. myop.& second. angle-clos.glauc.develop,  tens.eff., Kspar.diuret., Ksupplem. or salt substit.contain.K may   diomyopathy (HOCM), sev.ren.impairm., bil.ren. art. stenos., ren.art.
                                                                  stenos.in pres.of singl.kidn., aort. stenos., concom.K -spar.diurets.,
                                                                                        +
                                          -
                                                -
       Interactions: Other antihypertens.drugs may incr. antihypertens.eff.,
       rev.incr.in ser.Li conc.& toxic. dur.concur.use ACE inhib.& thiazides, act.   lead to incr. serum K, alcoh,barbits.& narcots.may potent orthostat.   Li/aliskiren-cont. prod., porphyr., concom.hydrochlorothiaz.not to
                                                                  be giv.in Addison’s dis., anur., sulphonam. hypersens., pregn.& lac-
                                     hypotens., diuret.induc.hypokalaem. may accent.card.arrhythm.,
       of curare derivat.potent., antihypertens.& diuret. eff.weak.by NSAIDs,   cholestyramine resin & colestipol HCl delay/decr.hydrochlorothiaz.   tat., hepat.impairm.
       system.expos.of valsartan incr.with concom. inhibits.of hepat.uptake   Side effects: Very common: Headache. Common: Dizzin., fatig.,
       transport. OATP1B1 (rifampicin/ciclosporin)/ hepat. efflux transport.   absorpt., incr.risk of Li toxic., NSAID’s reduc. diuret.eff., non depola-  asthen., insomn., dizzin., palpitat., tachycard., cough, pharyngit., nas.
                                     ris.musc.relax.eff.potent.
                                 +
       MRP2 (ritonavir), K-spar. diuret./-supplem./-salt substit.may alt.K lev.,   congest., sinus disord., URTI, diarrh., naus., abdom. pain, dyspeps.,
       kaliuret. diuret./ corticoster./ACTH/amphotericin/ carbenoxolone /  COPALIA, Novartis [P/S]  back/chest pain, musc.cramps, oed., swell., hyperkalaem., elev.ALT.
       penicill.G & salicylic acid.deriv. may incr.hypokalaem.eff., hypona-  Amlodipine 5 mg, valsartan 160 mg.  Uncommon: Orthostat. hypotens., rash, anorex., hyperuricaem., vom-
       trem.eff.of diurets. may be intensif.by concom.anti-depress./ antipsy-  Amlodipine 10 mg, valsartan 160 mg.  it., urticar. Rare: Thrombocytopen., hyperglycaem., paraesthes., jaund.,
       chots./ antiepilepts, incr.incid.of hypersens. reacts.to allopurinol, incr.  Indications: Mild to mod.essent.hypertens.in pts. stabilis.on same   photosens., glycosur. Very rare: Leukopen., agranulocytos., haemolyt.
       advers.effs. from amantadine, enhanc.hyperglycaem.eff.of diazoxide,   dos.of indiv.compon.  anaem., resp.distress incl.pneumonit.& pulm. oed.. pancreatit., necro-
       reduc.ren.excret.of cytotox.drugs potent.their myelosuppress.effs.,   (S3) TABS. 45/7.1.3/0850, 0851  tis.angiitis. Unknown: Erect.dysfunct./impot., aplast.anaem., anaphy-
       anticholinerg. agents incr.bioavail., haemolyt.anaem.with methyl-  721593-001: 5(160) mg, 28, R190.00  lact. reacts.,angioed., hyponatraem., restlessn., dysgeus., xanthops.,
       dopa, cholestryamine decr.thiazide diuret. absorpt., vit.D or Ca salts   721594-001: 10(160) mg, 28, R220,00  trans.blurr.vis., vertigo, vasculit.incl. Henoch-Schoenlein purpura, gastr.
       potent.rise in ser.Ca, cyclospor. may incr.risk of hyperuricaem.& gout   Dosage: Pts.using same compon.dos.from separ. tabs.may be switch.   irrit., sialoadenit., hepatit., purpura, prurit., tox. epiderm. necrolys., cu-
       type complicat., alcoh./anaesthet.& sedat.may potent. orthostat.hy-  Recomm.dos: 1 tab./day.  tan.lupus erythematos., erythroderma, arthralg., ren.dysfunct./fail., in-
       potens., decr.response to pressor amines  Contraindications: Angio-oed.with prev.ACE-inhibit./ angiotens.  terstit. nephrit., fev., weakn., malaise, liv.funct. abnorm.
       CO-ZOMEVEK, (Sandoz) Novartis  recept.block., heredit./idiopath. angioed., hypertroph.obstruct.car-  Warnings and special precautions: No re-challenge aft.angioed.
                                     diomopathy, aort. stenos., sev.ren.impairm., bilat.& unilat.ren.artery
       Valsartan 80(160; 160) mg, hydrochlorothiazide 12,5(12,5; 25) mg.  stenos., concom. K spar.diurets., porphyr., Li.ther., safety in pregn.&   react., poss.Li-toxic., ther.to be discont.immed.if pregn.confirm.& al-
                                             +
       Indications: Mild to mod.hypertens.in pts.stabil. on same dos.  lactat.not est., safety & effic.in childr. & adolesc.und.18 yrs.not est.  tern.ther. init. where appropr., switch to altern. antihypertens. when
       of indiv.compon.              Side effects: Nasopharyngit., flu., hypersens.incl. ser. sickn., anx.,   pregn.plann., adeq. contracept. in women of childbear.potent., pass.
       (S3) TABS, 43/7.1.3/0080, 0081, 0082  headache, dizzin., paraesthes., CNS effs., vertigo, tinnit., tachycard.,   through placenta & excret.in breast milk, hypersens., where ren.
       715558-001: 80/12,5 mg, 28, R159,87  palpitat., syncope, orthostat.hypotens., hypotens., cough, pharyngo-  funct.depend.on renin-angiotens. syst., correct. intravasc.vol.deplet.
       715559-001: 160/12,5 mg, 28, R159,87  laryng. pain, GI/vis.disturbs., skin reacts. incl.erythem.multiforme,   bef. init./ low.dos., period.ser.electrol.monit., dos. adjustm. of anti-
       715560-001: 160/25 mg, 28, R159,87  hyperhidros., joint swell., back pain, arthralg., musc.cramps, heavin.  diabet.agents poss., decr.urin.Ca excret. lead.to poss.elev.ser.Ca lev.,
       Dosage: Init.once pt.stabil.at same dos.of the indiv.compon.  sens., pollakiur., polyur., erect.dysfunct., pitt./fac./ periph./ oed., fatig.,   incr.cholester. & trigylcer. lev., poss.hyperuricaem.&/gout precipit. in
       Contraindications: Pregn., lactat., angioed. with prev.ARB ther.,   flush., asthen., hot flush., bld. dyscras., hyperglycaem., periph.neu-  cert. pts., safety & effic.in childr.not est., not to be giv. in lact.intol.
       heredit./idiopath.angioed., sev.hepat.impairm., bil.cirrhos.& choles-  ropathy, pancreatit., hepatit., angioed., vasculit., dyspn., rhinit., gingiv.  pts., hypersens. reacts. with/without allerg./bronch.asthma hist.,
       tas., Addisons dis., anuria, mod.to sev.ren.impairm., concom.Li ther.,   hyperplas., dry mouth, alopec., incr. sweat., incr.urin.freq., malaise,   SLE activ./ exacerbat., concom.NSAIDs in pts.with compromis. ren.
       refract.hypokalaem., hyponatraem., hypercalcaem.& symptomat.   mood chang., depress., gynaecomast., incr.pulm.oed.incid.in NYHA   funct., admin.1 hr bef. cholestyramine/ colestipol, concom.aliskiren
                                                                  not to be admin.in diab.pts.& avoid use in ren impairm., dual block.
       hyperuricaem., safety & effic.in childr. not est., safety in porphyr.not   III & IV HF of non-ischaem.aetiol., vir.infect., URTI, decr.libido, card.
       est., hypertroph.obstruct. cardiomyopathy, bil.ren.artery stenos., ren.  fail., ren.insuff., ac.ren.fail.  of RAAS with ARBs/ACE inhib.&/ aliskiren.
       artery stenos.with sngl.kidn., aort.stenos., concom.K  spar.diuret.  Warnings and special precautions: No re-challenge aft.an-  Drug interactions: Poss.reduc.act.metabol.lev. with rifampicin/flu-
                             +
                                                                                            +
                                                                           +
                                                                  conazole, incr.ser. K  with meds. block.angiotens.II or its eff./K spar.
       Side effects: Symptomat.hypotens., headache, dizzin., naso pharyn-  gioed.react., concom. Li ther., discont. ther.when pregn. confirm./  +   +
       git., fatig., URTI, cough., GI disturbs., arthralg., back/chest/abdom./  plann., effect. contracept. in women of childbear.potent., excret. in   diurets./K supplem./ K salt substit., reduc.Li excret., antihypertens.
                                                                  eff.poss.attenuat.by NSAIDs incl select. Cox-2 inhib., alcoh./barbit./
       neck/ extremity & leg pain, CNS effs., arthrit., asthen., bronchit.,   milk of lactat.rats, hepat./sev.ren.impairm., bil. obstruct.disords., con-
       dyspn., dry mouth, hyperhidros., hypoaesthes., hypokalaem., hy-  com. K -spar.diuret./K  supplem./ K salt substit.or meds.incr. K lev.,   narcot.potent. orthostat. hypotens., addit.eff./potent.with other an-
                                                                  tihypertens., imp.hydrochlorothiaz.absorpt.in pres. of anion.exchange
                                        +
                                              +
                                                    +
                                                               +
       potens., influenza, sprains & strains, nas./sin.congest., periph.oed.,   treatm. to be stopp.& chang.if pregn.occurs, Na & vol.deplet. theref.  resins, intensif.electrol. deplet. with corticoster./ACTH/glycyrrhizin,
       palpitat., paraesthes., pyrex., rash, tachycard., tinnit., UTI, vir.infect.,   correct.bef. init.ther.  decr. respons.to press.amin., incr.responsiven.to nondepolaris. skelet.
       blurr.vis., vertigo, hypersens. reacts.incl.ser.sickn.& vasculit., ren.   Drug interactions: Ser.Li conc.incr./toxic., incr. K  lev with K -spar.  musc.relax., NSAID’s may reduc. diuret., natriuret.& antihypertens.
                                                         +
                                                              +
       impairm./fail., myalg., pulm.oed.with granulocyt. infiltrat. & IgG de-  diuret./ K  supplem.or K salt substit./other meds.that may incr.K   +  eff.of loop/ K spar./thiazide diuret.
                                               +
                                         +
                                                                        +
       posit.in alveol.membr., decr. libido, elev.LFT, urticar.& other rash, erect.   lev.incl. heparin.
       dysfunct., photosensitisat., cholestas./jaund., sleep disord., depress.,   DIOVAN, Novartis [P/S]
       thrombocytopen.with purpura, necrotis.vasculit., tox.epiderm. necro-  COZAAR, MSD [P/S] & [N/P/S]  Valsartan.
       lys., cutan.lupus.erythematos like reacts., bld. dyscras., bone marr.de-  Losartan  Indications: Mild to mod.hypertens., improv. surviv. foll.MI in clinic.
       press., pancreatit., resp. distress.incl.pneumonit.& hypomagnesaem.,   Indications: Hypertens., ren.protect.in type 2 diab. with hyper-  stab.pts.with S&S or radiologic. evid.of left ventric.fail./left ventric.
       electrol.disords., elev.ser.Ca, activ./ aggrav.SLE  tens.& proteinur.  systol. dysfunct., HF (NYHA class II-IV).</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page147.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page143.html">143</a>&nbsp;&nbsp;&nbsp;<a href="page144.html">144</a>&nbsp;&nbsp;&nbsp;<a href="page145.html">145</a>&nbsp;&nbsp;&nbsp;<a href="page146.html">146</a>&nbsp;&nbsp;&nbsp;<a href="page147.html">147</a>&nbsp;&nbsp;&nbsp;<a href="page148.html">148</a>&nbsp;&nbsp;&nbsp;<a href="page149.html">149</a>&nbsp;&nbsp;&nbsp;<a href="page150.html">150</a>&nbsp;&nbsp;&nbsp;<a href="page151.html">151</a>&nbsp;&nbsp;&nbsp;<a href="page152.html">152</a>&nbsp;&nbsp;&nbsp;<a href="page153.html">153</a>
             </td>
             <td width="35%"><a href="page149.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page149.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
